FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40456911000001106: Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Feb 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2130341000001117 Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2130351000001119 Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has AMP Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Is a Generic Kaftrio 37.5mg/25mg/50mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Tezacaftor true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Ivacaftor true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Elexacaftor true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start